Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging Gut Microbiome and Immune System Dynamics During Immunotherapy to Develop Biomarkers of Response in Patients With Lung and Melanoma Cancer' and 'Intestinal Microbiota Profiling in Gynecologic Cancers to Identify Response-relevant Factors During Immune Checkpoint Blockade'

NCT07815873 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT07815873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07815873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging Gut Microbiome and Immune System Dynamics During Immunotherapy to Develop Biomarkers of Response in Patients With Lung and Melanoma Cancer' and 'Intestinal Microbiota Profiling in Gynecologic Cancers to Identify Response-relevant Factors During Immune Checkpoint Blockade'
Lead sponsor
European Institute of Oncology
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
April 1, 2031
Enrollment
360 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, melanoma (skin cancer), non small cell lung cancer